|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61K 38/00 | (2013.01) | ||
| C07K 14/745 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K2319/31 | (2013.01) | ||
| C07K 14/755 | (2013.01) | ||
| A61K 38/37 | (2013.01) | ||
| A61P 7/04 | (2018.01) | ||
| C12N 15/62 | (2013.01) |
| (11) | Patento numeris | 3458085 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17724760.8 |
| Europos patento paraiškos padavimo data | 2017-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/059976 |
| Data | 2017-04-26 |
| (87) | Numeris | WO 2017/198435 |
| Data | 2017-11-23 |
| (30) | Numeris | Data | Šalis |
| 16170690 | 2016-05-20 | EP |
| (72) |
KANNICHT, Christoph , DE
SOLECKA-WITULSKA, Barbara , DE
WINGE, Stefan , SE
SCHWIENTEK, Tilo , DE
|
| (73) |
Octapharma AG ,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | GLYCOSYLATED VWF FUSION PROTEINS WITH IMPROVED PHARMACOKINETICS |
| GLYCOSYLATED VWF FUSION PROTEINS WITH IMPROVED PHARMACOKINETICS |